Fennec Pharmaceuticals (FENC) Gross Margin (2023 - 2026)
Fennec Pharmaceuticals (FENC) reported Gross Margin of 95.97% for Q2 2026, up 5.98 percentage points from 89.98% a year earlier.
Powered by 
Analysis
Fennec Pharmaceuticals (FENC) Gross Margin (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Fennec Pharmaceuticals' Gross Margin came in at 92.35%, up 2.46 percentage points year-over-year; for FY2025, it was 91.57%, down 1.73 percentage points from FY2024.
- Gross Margin has a three-year change of +9.66 percentage points (FY2022 to FY2025).
- By year, Gross Margin came in at 93.30% in FY2024 (-0.77 pp), 94.08% in FY2023 (+12.17 pp) and 81.91% in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Gross Margin since Q1 2024.
- Year over year, Gross Margin gained in two of the last seven quarters, with an average year-over-year change of -0.53 percentage points.
- The high point for year-over-year Gross Margin in five years was Q3 2025 (a gain of 14.16 percentage points); the low point was Q3 2024 (a drop of 14.38 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 75.71% |
| 10 | Fennec Pharmaceuticals | 370.66 Mn | 230.50 Mn | 17.15 Mn | 95.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 95.97% |
| Mar 31, 2026 | 96.23% |
| Dec 31, 2025 | 87.20% |
| Sep 30, 2025 | 94.70% |
| Jun 30, 2025 | 89.98% |
| Mar 31, 2025 | 95.74% |
| Dec 31, 2024 | 91.56% |
| Sep 30, 2024 | 100.00% |
| Jun 30, 2024 | 91.63% |
| Mar 31, 2024 | 97.83% |
| Dec 31, 2023 | 92.96% |
| Sep 30, 2023 | 94.92% |
| Jun 30, 2023 | 95.55% |
| Mar 31, 2023 | 94.34% |
API Access
Fennec Pharmaceuticals Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=FENC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "FENC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=FENC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();